Free Trial

Zentek (CVE:ZEN) Trading Down 15.6% - Time to Sell?

Zentek logo with Medical background

Zentek Ltd. (CVE:ZEN - Get Free Report) shares were down 15.6% on Monday . The company traded as low as C$1.08 and last traded at C$1.24. Approximately 313,825 shares were traded during mid-day trading, an increase of 611% from the average daily volume of 44,166 shares. The stock had previously closed at C$1.47.

Zentek Price Performance

The company has a debt-to-equity ratio of 4.97, a quick ratio of 7.59 and a current ratio of 2.06. The stock has a 50 day moving average of C$1.93 and a two-hundred day moving average of C$1.68. The stock has a market cap of C$134.58 million, a PE ratio of -12.36 and a beta of 0.77.

Insiders Place Their Bets

In other Zentek news, Senior Officer Colin Stuart Van Der Kuur sold 15,000 shares of Zentek stock in a transaction dated Thursday, May 8th. The stock was sold at an average price of C$2.20, for a total transaction of C$33,000.00. 6.01% of the stock is currently owned by company insiders.

About Zentek

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Zentek Right Now?

Before you consider Zentek, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.

While Zentek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Watch Before Monday: Stocks to Load Up on Before Earnings
3 Hot Growth Stocks to Watch Right Now!
Don’t Miss These Top 3 Defense Stocks Set To Gain

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines